418 related articles for article (PubMed ID: 28834075)
1. Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: A systematic review.
Khunti K; Gomes MB; Pocock S; Shestakova MV; Pintat S; Fenici P; Hammar N; Medina J
Diabetes Obes Metab; 2018 Feb; 20(2):427-437. PubMed ID: 28834075
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic inertia in patients treated with two or more antidiabetics in primary care: Factors predicting intensification of treatment.
Mata-Cases M; Franch-Nadal J; Real J; Gratacòs M; López-Simarro F; Khunti K; Mauricio D
Diabetes Obes Metab; 2018 Jan; 20(1):103-112. PubMed ID: 28656746
[TBL] [Abstract][Full Text] [Related]
3. The 2018 update of the American College of Physicians glycaemic management recommendations: An invitation to continued inertia?
Morales J; Assumpcao-Morales M
Diabetes Obes Metab; 2018 Aug; 20(8):1809-1811. PubMed ID: 29658190
[TBL] [Abstract][Full Text] [Related]
4. An alternative approach to modelling HbA1c trajectories in patients with type 2 diabetes mellitus.
McEwan P; Bennett H; Qin L; Bergenheim K; Gordon J; Evans M
Diabetes Obes Metab; 2017 May; 19(5):628-634. PubMed ID: 28026908
[TBL] [Abstract][Full Text] [Related]
5. Clinical inertia in the treatment of hyperglycemia in type 2 diabetes patients in primary care.
Mata-Cases M; Benito-Badorrey B; Roura-Olmeda P; Franch-Nadal J; Pepió-Vilaubí JM; Saez M; Coll-de-Tuero G;
Curr Med Res Opin; 2013 Nov; 29(11):1495-502. PubMed ID: 23944631
[TBL] [Abstract][Full Text] [Related]
6. Towards an improved global understanding of treatment and outcomes in people with type 2 diabetes: Rationale and methods of the DISCOVER observational study program.
Ji L; Bonnet F; Charbonnel B; Gomes MB; Kosiborod M; Khunti K; Nicolucci A; Pocock S; Rathmann W; Shestakova MV; Shimomura I; Watada H; Fenici P; Hammar N; Hashigami K; Macaraeg G; Surmont F; Medina J
J Diabetes Complications; 2017 Jul; 31(7):1188-1196. PubMed ID: 28499961
[TBL] [Abstract][Full Text] [Related]
7. Improving type 2 diabetes mellitus glycaemic outcomes is possible without spending more on medication: Lessons from the UK National Diabetes Audit.
Heald AH; Livingston M; Malipatil N; Becher M; Craig J; Stedman M; Fryer AA
Diabetes Obes Metab; 2018 Jan; 20(1):185-194. PubMed ID: 28730750
[TBL] [Abstract][Full Text] [Related]
8. Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin.
Khunti K; Nikolajsen A; Thorsted BL; Andersen M; Davies MJ; Paul SK
Diabetes Obes Metab; 2016 Apr; 18(4):401-9. PubMed ID: 26743666
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. Delays in treatment intensification with oral antidiabetic drugs and risk of microvascular and macrovascular events in patients with poor glycaemic control: An individual patient simulation study.
Folse HJ; Mukherjee J; Sheehan JJ; Ward AJ; Pelkey RL; Dinh TA; Qin L; Kim J
Diabetes Obes Metab; 2017 Jul; 19(7):1006-1013. PubMed ID: 28211604
[TBL] [Abstract][Full Text] [Related]
11. Analysis of English general practice level data linking medication levels, service activity and demography to levels of glycaemic control being achieved in type 2 diabetes to improve clinical practice and patient outcomes.
Heald A; Davies M; Stedman M; Livingston M; Lunt M; Fryer A; Gadsby R
BMJ Open; 2019 Sep; 9(9):e028278. PubMed ID: 31494602
[TBL] [Abstract][Full Text] [Related]
12. Estimating the effect of sulfonylurea on HbA1c in diabetes: a systematic review and meta-analysis.
Hirst JA; Farmer AJ; Dyar A; Lung TW; Stevens RJ
Diabetologia; 2013 May; 56(5):973-84. PubMed ID: 23494446
[TBL] [Abstract][Full Text] [Related]
13. Prevention of cardiovascular disease through reduction of glycaemic exposure in type 2 diabetes: A perspective on glucose-lowering interventions.
Roussel R; Steg PG; Mohammedi K; Marre M; Potier L
Diabetes Obes Metab; 2018 Feb; 20(2):238-244. PubMed ID: 28597588
[TBL] [Abstract][Full Text] [Related]
14. Gaps and barriers in the control of blood glucose in people with type 2 diabetes.
Blonde L; Aschner P; Bailey C; Ji L; Leiter LA; Matthaei S;
Diab Vasc Dis Res; 2017 May; 14(3):172-183. PubMed ID: 28467203
[TBL] [Abstract][Full Text] [Related]
15. Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: The EXAMINE trial.
Heller SR; Bergenstal RM; White WB; Kupfer S; Bakris GL; Cushman WC; Mehta CR; Nissen SE; Wilson CA; Zannad F; Liu Y; Gourlie NM; Cannon CP;
Diabetes Obes Metab; 2017 May; 19(5):664-671. PubMed ID: 28058763
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of evogliptin monotherapy in patients with type 2 diabetes and moderately elevated glycated haemoglobin levels after diet and exercise.
Park J; Park SW; Yoon KH; Kim SR; Ahn KJ; Lee JH; Mok JO; Chung CH; Han KA; Koh GP; Kang JG; Lee CB; Kim SH; Kwon NY; Kim DM
Diabetes Obes Metab; 2017 Dec; 19(12):1681-1687. PubMed ID: 28448688
[TBL] [Abstract][Full Text] [Related]
17. Patterns of glycaemic control in patients with type 2 diabetes mellitus initiating second-line therapy after metformin monotherapy: Retrospective data for 10 256 individuals from the United Kingdom and Germany.
Khunti K; Godec TR; Medina J; Garcia-Alvarez L; Hiller J; Gomes MB; Cid-Ruzafa J; Charbonnel B; Fenici P; Hammar N; Hashigami K; Kosiborod M; Nicolucci A; Shestakova MV; Ji L; Pocock S
Diabetes Obes Metab; 2018 Feb; 20(2):389-399. PubMed ID: 28817227
[TBL] [Abstract][Full Text] [Related]
18. Diabetes Technology-Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline.
Peters AL; Ahmann AJ; Battelino T; Evert A; Hirsch IB; Murad MH; Winter WE; Wolpert H
J Clin Endocrinol Metab; 2016 Nov; 101(11):3922-3937. PubMed ID: 27588440
[TBL] [Abstract][Full Text] [Related]
19. [INERTIA study: Clinical inertia in non-insulinized patients on oral hypoglycemic treatment. A study in Spanish primary and specialty care settings].
González-Clemente JM; Font B; Lahoz R; Llauradó G; Gambús G;
Med Clin (Barc); 2014 Jun; 142(11):478-84. PubMed ID: 23622897
[TBL] [Abstract][Full Text] [Related]
20. Phase III, efficacy and safety study of ertugliflozin monotherapy in people with type 2 diabetes mellitus inadequately controlled with diet and exercise alone.
Terra SG; Focht K; Davies M; Frias J; Derosa G; Darekar A; Golm G; Johnson J; Saur D; Lauring B; Dagogo-Jack S
Diabetes Obes Metab; 2017 May; 19(5):721-728. PubMed ID: 28116776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
